So will it be the next biolidics?
Now up...
Just by way of info. E-Development sold Impact which produces Equivir (vaccine) for a share swap with DSS for a price of 21 US cents, DSS is now trading at 25 US cents. So not just impact sold for 50 million usd + (4 cents USD x shares).
Also the guy is Nobel Prize winner I think their doctor
Also the guy is Nobel Prize winner I think their doctor
41
44
50
44
50
This will likely move 50% tomorrow!
Biolidics halted. Acquisition offer?
How high the roof to be through?
SmallSmall ( Date: 02-Mar-2020 07:47) Posted:
|
make 2-3 bids easy
noobnub ( Date: 22-Apr-2020 10:16) Posted:
|
Issue is no update lei. Radio silence. u write to management lei. I also wnat to CHIOGN
SmallSmall ( Date: 22-Apr-2020 12:34) Posted:
|
Any positive updates on their Covid research will send the stock doubling. :)
Just have to be patient. Players are hungry and loaded with profits from Biolidics and Clearbridge to play the next Covid winner. 
Again when it comes it will be fast and furious. :)
 
Just have to be patient. Players are hungry and loaded with profits from Biolidics and Clearbridge to play the next Covid winner. 
Again when it comes it will be fast and furious. :)
 
anything below 0.05 is cheap. 
noobnub ( Date: 22-Apr-2020 11:32) Posted:
|
easily trap many at 37 38
noobnub ( Date: 22-Apr-2020 10:16) Posted:
|
They announce some test previously... on covid last month, so it is also a covid play :
Singapore eDevelopment: Impact BioMedical's Equivir Performs Well Against A Board Range Of Viruses In Testing By Its Scientific Research Partner & Preparations Are Underway For Testing Of Equivir Against COVID-19.
02 Mar 2020 15:40
Singapore eDevelopment Limited's wholly-owned U.S. biomedical subsidiary, Impact BioMedical, Inc., has, through its scientific research partner, GRDG Sciences, LLC., conducted an additional round of testing of Equivir, a patented medical treatment and preventative drug, against a broad range of viruses. The tests results revealed that Equivir performed well against a broad range of viruses and validates the results of previous laboratory testing conducted at multiple independent facilities. These tests demonstrate the ability of Equivir to control viruses responsible for deadly infectious diseases. The unique ability of Equivir to inhibit viruses makes it a promising candidate for the treatment of COVID-19, the disease caused by SARS-CoV-2 or severe acute respiratory syndrome coronavirus 2...
Singapore eDevelopment: Impact BioMedical's Equivir Performs Well Against A Board Range Of Viruses In Testing By Its Scientific Research Partner & Preparations Are Underway For Testing Of Equivir Against COVID-19.
02 Mar 2020 15:40
Singapore eDevelopment Limited's wholly-owned U.S. biomedical subsidiary, Impact BioMedical, Inc., has, through its scientific research partner, GRDG Sciences, LLC., conducted an additional round of testing of Equivir, a patented medical treatment and preventative drug, against a broad range of viruses. The tests results revealed that Equivir performed well against a broad range of viruses and validates the results of previous laboratory testing conducted at multiple independent facilities. These tests demonstrate the ability of Equivir to control viruses responsible for deadly infectious diseases. The unique ability of Equivir to inhibit viruses makes it a promising candidate for the treatment of COVID-19, the disease caused by SARS-CoV-2 or severe acute respiratory syndrome coronavirus 2...
huat ah!!!!!!!!!!!!!
Wind22i ( Date: 22-Apr-2020 10:25) Posted:
|
Game just starting..
Maybe they will rotate to this...testing and covid vac play also
Maybe they will rotate to this...testing and covid vac play also
$0.04 here we come !
SmallSmall ( Date: 22-Apr-2020 10:21) Posted:
|
Anything Covid related will Choong especially related to Testing and vaccines.
huat ah !
huat ah !
SmallSmall ( Date: 22-Apr-2020 10:06) Posted:
|
So this one TP?
wolverine23 ( Date: 22-Apr-2020 10:15) Posted:
|
this can try que to short 36
Wind22i ( Date: 22-Apr-2020 10:15) Posted:
|